These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
744 related articles for article (PubMed ID: 17586387)
1. Intraoperative use of intravitreal triamcinolone in uveitic eyes having cataract surgery: pilot study. Okhravi N; Morris A; Kok HS; Menezo V; Dowler JG; Hykin PG; Lightman S J Cataract Refract Surg; 2007 Jul; 33(7):1278-83. PubMed ID: 17586387 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract. Dada T; Dhawan M; Garg S; Nair S; Mandal S J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079 [TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758 [TBL] [Abstract][Full Text] [Related]
4. Cataract surgery after intravitreal injection of triamcinolone acetonide. Jonas JB; Kreissig I; Degenring RF Eye (Lond); 2004 Apr; 18(4):361-4. PubMed ID: 15069430 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema. Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680 [TBL] [Abstract][Full Text] [Related]
6. Outcome of intravitreal triamcinolone in uveitis. Kok H; Lau C; Maycock N; McCluskey P; Lightman S Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide injection for the treatment of posterior uveitis. Ozkiris A Ocul Immunol Inflamm; 2006 Aug; 14(4):233-8. PubMed ID: 16911985 [TBL] [Abstract][Full Text] [Related]
8. Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6-month prospective pilot study. Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Lai WW; Fan DS; Chan WM Eye (Lond); 2005 Aug; 19(8):885-90. PubMed ID: 15389275 [TBL] [Abstract][Full Text] [Related]
9. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis. Chieh JJ; Carlson AN; Jaffe GJ Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220 [TBL] [Abstract][Full Text] [Related]
10. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema. Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Jonas JB Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641 [TBL] [Abstract][Full Text] [Related]
12. Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery. Kim SY; Yang J; Lee YC; Park YH J Cataract Refract Surg; 2008 May; 34(5):823-6. PubMed ID: 18471640 [TBL] [Abstract][Full Text] [Related]
13. Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis. Androudi S; Ahmed M; Fiore T; Brazitikos P; Foster CS J Cataract Refract Surg; 2005 Mar; 31(3):472-8. PubMed ID: 15811733 [TBL] [Abstract][Full Text] [Related]
14. Comparison between intravitreal and orbital floor triamcinolone acetonide after phacoemulsification in patients with endogenous uveitis. Roesel M; Tappeiner C; Heinz C; Koch JM; Heiligenhaus A Am J Ophthalmol; 2009 Mar; 147(3):406-12. PubMed ID: 19054496 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion. Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study. Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A Ophthalmic Res; 2009; 42(2):81-6. PubMed ID: 19478546 [TBL] [Abstract][Full Text] [Related]
17. Phacoemulsification cataract extraction and intraocular lens implantation in patients with uveitis. Kawaguchi T; Mochizuki M; Miyata K; Miyata N J Cataract Refract Surg; 2007 Feb; 33(2):305-9. PubMed ID: 17276275 [TBL] [Abstract][Full Text] [Related]
18. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Jaffe GJ; Martin D; Callanan D; Pearson PA; Levy B; Comstock T; Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of combined sutureless vitrectomy with triamcinolone stain to manage vitreous loss resulting from posterior capsule rupture during phacoemulsification. Chang CJ; Chiang SY; Chen CL; Wang TY J Cataract Refract Surg; 2006 Dec; 32(12):2054-9. PubMed ID: 17137983 [TBL] [Abstract][Full Text] [Related]
20. A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation. Paganelli F; Cardillo JA; Melo LA; Oliveira AG; Skaf M; Costa RA; Ophthalmology; 2004 Nov; 111(11):2102-8. PubMed ID: 15522378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]